Literature DB >> 23363068

Anti-obesity effects of galangin, a pancreatic lipase inhibitor in cafeteria diet fed female rats.

Shiv Kumar1, K R Alagawadi.   

Abstract

CONTEXT: Alpinia galanga Willd (Zingiberaceae) (AG) is a rhizomatous herb widely cultivated in shady regions of Malaysia, India, Indochina and Indonesia. It is used in southern India as a domestic remedy for the treatment of rheumatoid arthritis, cough, asthma, obesity, diabetes, etc. It was reported to have anti-obesity, hypoglycemic, hypolipidemic and antioxidant properties.
OBJECTIVE: A flavonol glycoside, galangin, was isolated from AG rhizomes. Based on its in vitro pancreatic lipase inhibitory effect, the study was further aimed to clarify whether galangin prevented obesity induced in female rats by feeding cafeteria diet (CD) for 6 weeks.
MATERIALS AND METHODS: The in vitro pancreatic lipase inhibitory effect of galangin was determined by measuring the release of oleic acid from triolein. For in vivo experiments, female albino rats were fed CD with or without 50 mg/kg galangin for 6 weeks. Body weight and food intake was measured at weekly intervals. On day 42, serum lipids levels were estimated and then the weight of liver and parametrial adipose tissue (PAT) was determined. The liver lipid peroxidation and triglyceride (TG) content was also estimated.
RESULTS: The IC50 value of galangin for pancreatic lipase was 48.20 mg/mL. Galangin produced inhibition of increased body weight, energy intake and PAT weight induced by CD. In addition, galangin produced a significant decrease in serum lipids, liver weight, lipid peroxidation and accumulation of hepatic TGs.
CONCLUSION: Galangin present in AG rhizomes produces anti-obesity effects in CD-fed rats; this may be mediated through its pancreatic lipase inhibitory, hypolipidemic and antioxidant activities.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23363068     DOI: 10.3109/13880209.2012.757327

Source DB:  PubMed          Journal:  Pharm Biol        ISSN: 1388-0209            Impact factor:   3.503


  13 in total

1.  Galangin inhibits hypertrophic scar formation via ALK5/Smad2/3 signaling pathway.

Authors:  Yifan Zhang; Shengzhou Shan; Jing Wang; Xinyu Cheng; Bo Yi; Jia Zhou; Qingfeng Li
Journal:  Mol Cell Biochem       Date:  2016-01-04       Impact factor: 3.396

2.  Galangin, a dietary flavonoid, improves antioxidant status and reduces hyperglycemia-mediated oxidative stress in streptozotocin-induced diabetic rats.

Authors:  Amal A Aloud; Chinnadurai Veeramani; Chandramohan Govindasamy; Mohammed A Alsaif; Ahmed S El Newehy; Khalid S Al-Numair
Journal:  Redox Rep       Date:  2016-12-28       Impact factor: 4.412

3.  Galangin: A metabolite that suppresses anti-neoplastic activities through modulation of oncogenic targets.

Authors:  Hardeep Singh Tuli; Katrin Sak; Shubham Adhikary; Ginpreet Kaur; Diwakar Aggarwal; Jagjit Kaur; Manoj Kumar; Nidarshana Chaturvedi Parashar; Gaurav Parashar; Uttam Sharma; Aklank Jain
Journal:  Exp Biol Med (Maywood)       Date:  2021-12-14

Review 4.  Potential of Natural Honey in Controlling Obesity and its Related Complications.

Authors:  Muhammad Faiz Zulkifli; Mohd Naim Fadhli Mohd Radzi; Jonel P Saludes; Doralyn S Dalisay; Wan Iryani Wan Ismail
Journal:  J Evid Based Integr Med       Date:  2022 Jan-Dec

5.  Effect of propolis phenolic compounds on free fatty acid receptor 4 activation.

Authors:  Hyunnho Cho; Kyong Kim; Nayeon Kim; Minji Woo; Hye Young Kim
Journal:  Food Sci Biotechnol       Date:  2019-10-14       Impact factor: 2.391

Review 6.  Novel Investigations of Flavonoids as Chemopreventive Agents for Hepatocellular Carcinoma.

Authors:  Chen-Yi Liao; Ching-Chang Lee; Chi-chang Tsai; Chao-Wen Hsueh; Chih-Chiang Wang; I-Hung Chen; Ming-Kai Tsai; Mei-Yu Liu; An-Tie Hsieh; Kuan-Jen Su; Hau-Ming Wu; Shih-Chung Huang; Yi-Chen Wang; Chien-Yao Wang; Shu-Fang Huang; Yen-Cheng Yeh; Ren-Jy Ben; Shang-Tao Chien; Chin-Wen Hsu; Wu-Hsien Kuo
Journal:  Biomed Res Int       Date:  2015-12-16       Impact factor: 3.411

7.  Galangin, a dietary flavonoid, ameliorates hyperglycaemia and lipid abnormalities in rats with streptozotocin-induced hyperglycaemia.

Authors:  Amal A Aloud; Veeramani Chinnadurai; Chandramohan Govindasamy; Mohammed A Alsaif; Khalid S Al-Numair
Journal:  Pharm Biol       Date:  2018-12       Impact factor: 3.503

8.  Galangin Resolves Cardiometabolic Disorders through Modulation of AdipoR1, COX-2, and NF-κB Expression in Rats Fed a High-Fat Diet.

Authors:  Patoomporn Prasatthong; Sariya Meephat; Siwayu Rattanakanokchai; Juthamas Khamseekaew; Sarawoot Bunbupha; Parichat Prachaney; Putcharawipa Maneesai; Poungrat Pakdeechote
Journal:  Antioxidants (Basel)       Date:  2021-05-12

Review 9.  Inhibitors of pancreatic lipase: state of the art and clinical perspectives.

Authors:  Nitin A Lunagariya; Neeraj K Patel; Sneha C Jagtap; Kamlesh K Bhutani
Journal:  EXCLI J       Date:  2014-08-22       Impact factor: 4.068

10.  Wnt/β-catenin coupled with HIF-1α/VEGF signaling pathways involved in galangin neurovascular unit protection from focal cerebral ischemia.

Authors:  Chuanhong Wu; Jianxin Chen; Chang Chen; Wei Wang; Limei Wen; Kuo Gao; Xiuping Chen; Sihuai Xiong; Huihui Zhao; Shaojing Li
Journal:  Sci Rep       Date:  2015-11-05       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.